Shivalik Rasayan Ltd (SHIVALIK) AI Stock Analysis

• Market Cap: ₹4.18B
• Dividend Yield: 0.13%
• Average Volume (3M): 1.25K
• Price to Earnings (P/E): 51.2
• Beta (1Y): 0.97
• Revenue Growth: 6.69%
• EPS Growth: -29.48%
• Country: IN
• Employees: 267
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Agricultural Inputs
• EPS (TTM): 9.00
• Shares Outstanding: 15,750,365
• 10 Day Avg. Volume: 987
• 30 Day Avg. Volume: 1,247
• PEG Ratio: 2.26
• Price to Book (P/B): 1.90
• Price to Sales (P/S): 3.26
• P/FCF Ratio: -34.52
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 54 Neutral
• Price Target: ₹281.00 ▼(-21.67% Downside)
• Action: Reiterated Date: 03/26/26
• Date: Action: Reiterated 03/26/26

Positive Factors

Consistent revenue growth

Shivalik has delivered consistent top-line growth, with total revenue rising into 2025. Durable revenue expansion indicates sustained customer demand and product traction across its chemical and API portfolio, supporting predictable cash inflows and strategic reinvestment over 2-6 months.

Negative Factors

Persistent negative operating and free cash flow

Sustained negative operating and free cash flows mean the business is not converting profits into cash reliably. Over a multi-month horizon this undermines ability to fund working capital, service debt, or invest without external financing, raising structural liquidity risk.

Shivalik Rasayan Ltd Business Overview & Revenue Model

Company Description

Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. Its products include organophosphorous based insecticides and chemicals. The company was founded by Rahul Bishnoi on March 16, 1979 and is headquartered ...

Read more

Shivalik Rasayan Ltd. engages in the manufacture of pharmaceutical and agrochemical products. Its products include organophosphorous based insecticides and chemicals. The company was founded by Rahul Bishnoi on March 16, 1979 and is headquartered ...

How the Company Makes Money

The company primarily makes money by manufacturing and selling chemical products (including APIs, intermediates, and other specialty/fine chemicals) to customers, generating revenue from product sales. Its earnings are driven by volumes sold and r...

Read more

The company primarily makes money by manufacturing and selling chemical products (including APIs, intermediates, and other specialty/fine chemicals) to customers, generating revenue from product sales. Its earnings are driven by volumes sold and r...

Shivalik Rasayan Ltd Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	3.38B	3.12B	2.73B	2.34B	2.07B	1.96B
Gross Profit	1.30B	805.70M	1.33B	1.20B	533.21M	680.77M
EBITDA	503.80M	485.11M	461.64M	493.13M	534.26M	411.80M
Net Income	140.50M	166.96M	127.17M	212.35M	256.06M	176.02M
Balance Sheet
Total Assets	8.04B	7.34B	6.92B	5.78B	4.88B	3.63B
Cash, Cash Equivalents and Short-Term Investments	468.39M	279.69M	377.38M	306.71M	707.58M	47.73M
Total Debt	1.00B	938.83M	859.67M	655.12M	411.22M	301.48M
Total Liabilities	2.18B	1.98B	1.85B	1.59B	1.24B	1.03B
Stockholders Equity	5.87B	5.36B	3.90B	3.10B	2.87B	1.79B
Cash Flow
Free Cash Flow	-267.77M	-294.37M	-757.31M	-821.81M	-138.32M	-64.92M
Operating Cash Flow	-168.43M	-86.05M	-80.75M	-189.49M	111.34M	587.69M
Investing Cash Flow	-157.64M	-208.31M	-743.08M	-707.72M	-233.56M	-790.95M
Financing Cash Flow	514.76M	196.69M	894.49M	496.34M	782.07M	19.83M

Shivalik Rasayan Ltd Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 358.75
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:SHIVALIK, the sentiment is Neutral. The current price of 358.75 is above the 20-day moving average (MA) of 248.41, above the 50-day MA of 270.98, and below the 200-day MA of 402.63, indicating a neutral trend. The MACD of 1.17 indicates Negative momentum. The RSI at 57.48 is Neutral, neither overbought nor oversold. The STOCH value of 76.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:SHIVALIK.

Shivalik Rasayan Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SHREEPUSHK	74 Outperform	₹12.57B	17.66	―	0.52%	25.74%	32.15%
BHAGERIA	69 Neutral	₹7.24B	17.61	―	0.81%	32.26%	59.15%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
ZUARI	57 Neutral	₹10.05B	8.74	―	―	-9.53%	338.31%
BODALCHEM	56 Neutral	₹8.35B	697.51	―	―	11.11%	400.65%
SHIVALIK	54 Neutral	₹4.18B	51.21	―	0.13%	6.69%	-29.48%
HERANBA	49 Neutral	₹8.85B	-10.64	―	0.39%	―	―